Compliance with the Drug Supply Chain Security Act (DSCSA) continues to evolve and trading partners are beginning to see serialized product enter the supply chain. Hospital pharmacies and healthcare systems are now interested in how they can leverage the electronically available data and drug identifiers to enhance operations and better serve patients.
This Study has been initiated to determine how the new DSCSA information and product
marking may be leveraged to more efficiently and effectively remove recalled product
from the supply chain and maintain safe inventories for use with patients.
Click below to DOWNLOAD MORE INFO or to JOIN STUDY TEAMS: